Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.23.4
CONSOLIDATED BALANCE SHEETS - USD ($)
Nov. 30, 2023
Aug. 31, 2023
Current    
Cash $ 1,954,165 $ 1,352,102
Marketable securities 72,427 125,642
Accounts receivable 534,731 126,686
Prepaid expenses and other current assets 132,311 546,783
Total Current Assets 2,693,634 2,151,213
Non-current assets, net    
Long-term receivables 48,559 48,559
Right of use assets 156,565 167,446
Intellectual property, net 494,377 462,625
Property & equipment, net 233,639 254,143
Total Non-current Assets 933,140 932,773
TOTAL ASSETS 3,626,774 3,083,986
Current Liabilities    
Accounts payable and accrued liabilities 98,969 239,941
Lease liability, current 25,554 27,794
Total Current Liabilities 124,523 267,735
Lease liabilities - non-current 129,517 136,173
TOTAL LIABILITIES 254,040 403,908
Share Capital    
Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Common shares issued and outstanding 10,311,641 and 8,091,650 at 11/30/23 and 8/31/23, respectively. 10,311 8,091
Additional paid-in capital 50,670,556 48,799,454
Accumulated Deficit (46,942,750) (45,763,427)
Accumulated other comprehensive income 4,372 0
Equity attributable to shareholders of Lexaria 3,742,489 3,044,118
Non-controlling Interest (369,755) (364,040)
Total Stockholders' Equity 3,372,734 2,680,078
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 3,626,774 $ 3,083,986